American Medical Association Approves Groundbreaking New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Opening New Opportunities for Envoy Medical’s Esteem® Device
Envoy Medical, Inc. - Class A (COCH)
Company Research
Source: GlobeNewswire
The Esteem® device is the only totally implantable active middle ear implant with FDA Approval, allowing the Company to be the first to capitalize on the new codes WHITE BEAR LAKE, Minnesota, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Envoy Medical, Inc. (NASDAQ: COCH), a market leader in fully implanted hearing devices, today announced that the American Medical Association (AMA) Current Procedural Terminology (CPT) Editorial Panel has approved five Category III CPT codes for totally implantable active middle ear implants (AMEI), a crucial development for the Company’s already FDA-approved Esteem® product. This marks the first time that there will be CPT codes for totally implantable active middle ear hearing implants like the Esteem® device. The previous lack of CPT codes effectively limited market adoption of and prevented access to these groundbreaking, fully implanted hearing devices. With a new set of CPT codes, a path to reimbursement for the breakthrough Esteem® Fully Implanted Ac
Show less
Read more
Impact Snapshot
Event Time:
COCH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COCH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COCH alerts
High impacting Envoy Medical, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
COCH
News
- Envoy Medical Reports Third Quarter 2024 Results and Other Exciting EventsGlobeNewswire
- Envoy Medical’s Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed PublicationGlobeNewswire
- Envoy Medical Receives Another European Patent for its Modular Cochlear Implant SystemGlobeNewswire
- Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing DeviceGlobeNewswire
- Key Advocates Urge CMS to Clarify that Fully Implanted Active Middle Ear Hearing Devices are Prosthetic Devices for Purposes of Medicare CoverageGlobeNewswire
COCH
Analyst Actions
- 9/3/24 - Ascendiant Capital
COCH
Sec Filings
- 11/21/24 - Form 4
- 11/21/24 - Form 4
- 11/20/24 - Form 8-K
- COCH's page on the SEC website